The Patent Finder

Inhibitors of Cyclin-Dependent Kinase 7 (CDK7)

Medic Life Sciences, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 2 of these applications claim priority to application PCT/US2019/059542, filed Nov 1, 2019. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 10,738,067Inhibitors of Cyclin-Dependent Kinase 7 (CDK7)
In force
 · High confidence
UsedRemaining
Medic Life Sciences, Inc.In forceHigh confidence
US 12,240,869Inhibitors of Cyclin-Dependent Kinase 7 (CDK7)
In force
 · Medium confidence
Medic Life Sciences, Inc.In forceMedium confidence
Application 19/037,690Inhibitors of Cyclin-Dependent Kinase 7 (CDK7)
Pending
Not granted
Medic Life Sciences, Inc.PendingNot granted
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Medic Life Sciences, Inc..
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited